And, nCino's earnings come up short.
Plus, PVH's buyback boosts stock.
And, Eli Lilly's heart disease drug.
Should you buy or avoid this stock?
And, Toncoin's Grok AI price bump.
And, Bitcoin’s rough 2025, explained.
And, Tesla’s rough 2025, explained.
And, Dogecoin's open interest surge.
And, Kenvue's new investor pressure.
A 2025 screaming buy stock pick.
Plus, Nike's declining China sales.
And, Solana Futures ETFs launch.
